An explanatory video on NeurologyLive features Dr. James Galvin, MD, MPH, Chief Scientific Officer at Cognivue, discussing the clinical use of Cognivue Clarity^® and the new Cognivue Amyloid Risk Measure (CARM)*, and how these tools can inform clinical decisions and guide appropriate next steps in patient staging.